AJR 2005; 184:511-519
© American Roentgen Ray Society
CT and MRI Features of Pure Acinar Cell Carcinoma of the Pancreas in Adults
Servet Tatli1,2,
Koenraad J. Mortele1,
Angela D. Levy3,4,
Jonathan N. Glickman5,
Pablo R. Ros1,
Peter A. Banks6 and
Stuart G. Silverman1
1 Department of Radiology, Division of Abdominal Imaging and Intervention,
Brigham and Women's Hospital, Harvard Medical School, 75 Francis St., Boston,
MA 02115.
2 Department of Radiology, Dana Farber Cancer Institute, Boston, MA 02115.
3 Department of Radiologic Pathology, Armed Forces Institute of Pathology,
Washington, DC.
4 Department of Radiology, Uniformed Services University of Health Sciences,
Bethesda, MD.
5 Department of Pathology, Brigham and Women's Hospital, Harvard Medical School,
Boston, MA.
6 Division of Gastroenterology, Department of Medicine, Brigham and Women's
Hospital, Harvard Medical School, Boston, MA.
Received April 18, 2004;
accepted after revision July 19, 2004.
Address correspondence to S. Tatli
(statli{at}partners.org).
Abstract
OBJECTIVE. We sought to describe the CT and MRI features of pure
acinar cell carcinoma of the pancreas in adults.
MATERIALS AND METHODS. Eleven patients (six women and five men; mean
age, 64 years) with acinar cell carcinoma, documented by pathologic
examination of resected specimens, underwent CT (n = 9) or MRI
(n = 2) examinations. Two radiologists evaluated imaging studies and
determined, by consensus, the following data for each tumor: size, location,
margination, internal density or signal intensity, and contrast enhancement
pattern. In addition, they assessed the presence of calcification, pancreatic
or bile duct dilation, and metastases. Imaging features were correlated with
gross and microscopic pathologic features of the tumors.
RESULTS. Masses were distributed throughout the pancreas (head,
n = 5; body, n = 2; and tail, n = 4). The mean
largest dimensions were 6.0 x 5.3 cm (range, from 2 x 1.7 to 15
x 11 cm). Tumors were oval (n = 5), round (n = 4), or
lobular (n = 2). Ten (91%) masses were well marginated; nine (82%)
were exophytic. Five (45%) masses enhanced homogeneously; the remaining tumors
contained cystic areas. All masses enhanced less than the surrounding
pancreas. Three (27%) masses contained calcifications. Four (80%) masses
invaded the duodenum. Common bile and pancreatic duct dilatation was present
in two and three patients, respectively. One patient had metastatic liver
disease at presentation.
CONCLUSION. Pure acinar cell carcinoma of the pancreas is usually an
exophytic, oval or round, well-marginated, and hypovascular mass on CT and
MRI. It typically is completely solid when small and contains cystic areas due
to necrosis when large.
Introduction
Acinar cell carcinoma is a rare epithelial neoplasm of the pancreas that
shows evidence of acinar differentiation, occasionally with an endocrine
component
[1–4].
Although acinar cells make up most of the pancreatic parenchyma, acinar cell
carcinoma represents approximately 1% of exocrine pancreatic tumors
[1,
2]. Acinar cell carcinoma is
also known as acinic cell carcinoma and acinous cell carcinoma
[1]. With few exceptions,
acinar cell carcinoma occurs during the fifth to seventh decades of life
[3]. Tumor cells typically
produce pancreatic enzymes that occasionally can circulate systemically and
cause polyarthritis and subcutaneous fat necrosis
[1–3].
Pancreatic acinar cell carcinomas are relatively aggressive neoplasms; the
prognosis of patients with acinar cell carcinomas is better than that of
patients with ductal-type adenocarcinomas but worse than that of patients with
pancreatic endocrine tumors [2,
3].
Although the acinar cell carcinoma has been long recognized as a distinct
clinicopathologic entity, to our knowledge, a comprehensive analysis of their
CT and MRI features has not been reported. Case reports have described the CT
appearances of acinar cell carcinoma as a poorly defined, dense mass
[5], a well-defined mass with
central necrosis [6], a cystic
mass surrounded by a thick hypervascular wall
[7], a well-defined hypodense
mass with a thin, enhancing capsule
[8], and a well-defined,
hypervascular solid mass [9].
Acinar cell carcinoma showed avid uptake of mangafodipir trisodium on MRI in
one patient [10].
The objective of this study was to describe the CT and MRI findings of
acinar cell carcinoma of the pancreas in adults.
Materials and Methods
Patients
We reviewed the surgery and pathology records and radiologic studies for
patients who had been seen at two academic institutions over a 17-year period
(1985–2002) and identified 16 patients with pathologically proven acinar
cell carcinoma of the pancreas. Five cases were excluded because of
unavailability of preoperative imaging (n = 2), mixed
acinar–endocrine carcinoma (n = 2), and mixed
acinar–ductal carcinoma (n = 1). Therefore, 11 patients with
pure acinar cell carcinoma of the pancreas who underwent preoperative CT or
MRI were studied. Institutional review board approval for the study was
obtained in both institutions.
Our study population included six women and five men with a mean age of 64
years (range, 44–79 years). Ten patients were white, and one was
Hispanic. Nine patients (82%) presented with epigastric and right upper
quadrant pain (n = 6), jaundice (n = 1), back pain
(n = 1), or painful skin nodules and arthralgias (n = 1).
The median time interval between onset of clinical symptoms and the pathologic
diagnosis was 8 months (range, 1–36 months). In two patients, tumors
were discovered incidentally on a chest CT scan obtained for shortness of
breath (n = 1) and for chest tightness (n = 1). Tumors were
palpable in two patients (18%). One of the patients with recurrent epigastric
pain had been mistakenly diagnosed with chronic pancreatitis, and the tumor
had been misdiagnosed as a pseudocyst. Of nine patients for whom laboratory
data were available, three had elevated serum lipase or amylase levels, and
one patient had an elevated serum bilirubin level.
All patients underwent surgical resection of the tumor either with distal
pancreatectomy (n = 6), pancreaticoduodenectomy (Whipple procedure)
(n = 4), or a palliative tumor resection with gastrojejunostomy
(n = 1).
Imaging Technique and Analysis
Nine patients underwent CT examinations, eight with IV contrast material.
Two had both unenhanced and enhanced scans. One patient had only an unenhanced
CT scan. Two patients underwent MRI, one with IV gadolinium and one without.
Both MRI examinations included unenhanced T1-weighted spin-echo images and
T2-weighted fast spin-echo images. Spoiled gradient-recalled echo images with
fat suppression were obtained before and after the IV administration of
gadopentetate dimeglumine (2 mmol/kg of body weight). Contrast-enhanced CT or
MR images were obtained during the arterial phase (n = 3) and portal
venous phase (n = 6).
Two abdominal radiologists blinded to pathologic findings evaluated in
consensus all images retrospectively. They evaluated the following morphologic
features: location of the tumor in the pancreas (head, body, or tail); maximal
transverse diameters of the tumor; shape (round, oval, or lobulated); and
presence of calcifications. Internal density or signal intensity
characteristics of the tumor were compared with those of surrounding pancreas
and were described as hypo-, iso-, or hyperdense or intense and as homogeneous
or heterogeneous. If areas of water density or signal intensity were seen, the
tumor was classified as cystic. The fraction of tumor composed of cystic
material versus solid material was estimated and expressed as a percentage.
Finally, the enhancement pattern of the tumor (hypovascular or hypervascular
compared with normal pancreas) was evaluated in nine patients. Images were
also evaluated for common bile and pancreatic duct obstruction; vascular
invasion; and tumor spread to regional lymph nodes, adjacent solid organs, and
other abdominal sites.
Pathologic Examination and Analysis
Two pathologists, one at each institution, reviewed the gross tumor
specimen and H and E–stained microscopic slides. CT and MRI features
were correlated with gross pathologic and histologic findings in each case. In
addition to morphologic characteristics of the tumor, pathologists recorded
the presence of lymph node metastases, bile or pancreatic duct dilatation,
invasion of visceral vessels, and involvement of surrounding organs.
Results
CT and MRI Analysis
Tumors averaged 6.0 x 5.3 cm (range, from 2.0 x 1.7 to 15
x 11 cm) in dimensions and were located in the pancreatic head
(n = 5), tail (n = 4), and body (n = 2). In nine
patients (82%), the tumors were partially or completely exophytic
(Fig. 1). Tumors were well
marginated in 10 cases (91%) and appeared oval, round, and lobular in five,
four, and two cases, respectively.
View larger version (140K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 1. —63-year-old man with history of prostate cancer who was found
to have pancreatic mass on chest CT scan obtained for evaluation of shortness
of breath. Unenhanced CT image of pancreas shows oval, homogeneous mass
(arrows) in pancreatic tail. Note exophytic location of well-defined
mass.
|
|
Both reviewers agreed in all cases for all MRI features studied. On
unenhanced CT and MRI, the masses appeared homogeneous in five cases (45%) and
heterogeneous in six cases (55%). Tumors appeared completely solid in five
cases (Fig. 2A,
2B) and cystic in six. The
cystic areas composed more than 75% of the mass in four cases, between 50% and
75% in one, and less than 25% in one. All cystic masses had at least one solid
component, usually in the periphery (Fig.
3). The mean diameters of solid tumors and tumors with cystic
areas were 3.5 and 10.1 cm, respectively. Calcifications were observed in
three masses (27%) (small and punctate in two, thick and peripheral in one
[Fig. 4A,
4B]). One mass showed
hyperintense areas on T1-weighted images suggestive of hemorrhage.
Intratumoral hemorrhage could not be evaluated in six patients who had only
enhanced CT.
View larger version (126K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 3. —66-year-old man who presented with epigastric mass
(arrows), jaundice, and pruritus. Axial CT scan shows large,
well-marginated, heterogeneous mass arising from pancreatic head. Note central
necrotic and peripheral solid areas.
|
|
On enhanced CT, four (100%) of four solid masses enhanced homogeneously but
less than the surrounding normal pancreas. Five (100%) of five cystic masses
that underwent contrast-enhanced imaging showed homogeneous enhancement of the
peripheral solid components. These solid components enhanced less than
surrounding pancreas (Fig. 5A,
5B,
5C,
5D,
5E).
View larger version (132K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 5A. —55-year-old woman who presented with intermittent epigastric
pain over 3-year period. Axial CT scan shows well-marginated exophytic mass
(arrows) in pancreatic head with central necrosis and hypovascular
enhancement in peripheral component. Note punctate calcification
(arrowhead).
|
|
View larger version (181K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 5D. —55-year-old woman who presented with intermittent epigastric
pain over 3-year period. Low-power photomicrograph shows nests of tumor cells
separated by thin fibrovascular septa. (H and E, x40)
|
|
View larger version (166K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 5E. —55-year-old woman who presented with intermittent epigastric
pain over 3-year period. High-power view of tumor cells shows round nuclei,
prominent nucleoli, and abundant eosinophilic cytoplasm containing zymogen
granules. (H and E, x200)
|
|
One tumor examined on MRI was solid and slightly hypointense on T1-weighted
and hyperintense on T2-weighted images in comparison with pancreatic
parenchyma. It enhanced homogeneously but less than surrounding pancreatic
parenchyma (Fig. 6A,
6B,
6C,
6D). The second tumor was
partially cystic and well marginated. It had a large central necrotic area
with mixed T1 signal intensity and hyperintense T2 signal intensity.
View larger version (150K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 6C. —48-year-old man who presented with epigastric pain and
elevated serum amylase level. After IV injection of gadolinium, no clear
enhancement of mass (arrow) is seen on axial fat-suppressed
gradient-recalled echo arterial (C) and portal venous (D) phase
images.
|
|
View larger version (140K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 6D. —48-year-old man who presented with epigastric pain and
elevated serum amylase level. After IV injection of gadolinium, no clear
enhancement of mass (arrow) is seen on axial fat-suppressed
gradient-recalled echo arterial (C) and portal venous (D) phase
images.
|
|
Pancreatic and bile duct dilatation were seen in three and two patients,
respectively. In two patients, both pancreatic and bile ducts were dilated.
Four of five masses located in the pancreatic head showed duodenal invasion
(Fig. 7A,
7B). In one patient, the
duodenum was compressed by the mass but had not been invaded. On CT and MRI,
the tumor was shown to have invaded the stomach (n = 1), transverse
mesocolon (n = 1), portal venous confluence (n = 1), and
splenic vein (n = 1). One patient had a subcentimeter indeterminate
liver lesion at initial presentation that was proven to be a metastasis at
surgery; one patient developed a liver metastasis during follow-up. No
lymphadenopathy was detected.
View larger version (146K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 7A. —78-year-old woman who presented with right upper quadrant
pain. Upper gastrointestinal series shows that mass is invading second portion
of duodenum (arrows). Note markedly narrowed second portion of
duodenum (thin vertical collection of barium anteriorly)
(arrowheads).
|
|
Correlation with Pathologic Findings: Gross Morphologic and Immunohistochemical Features
The relative proportions of solid and cystic areas varied greatly among the
tumors (from totally solid to markedly cystic) but correlated well with CT and
MRI findings (Fig. 8A,
8B,
8C,
8D). Six tumors had necrotic
areas, and two had hemorrhagic areas, one of which was not visible on CT. The
duodenum was invaded by tumor in four patients and displaced markedly without
invasion in one patient, as could be predicted from the preoperative imaging.
Focal splenic artery invasion with tumor thrombus (n = 1), invasion
of the portal–splenic venous confluence (n = 1), invasion of
the adjacent stomach and transverse mesocolon including midcolic vessels
(n = 1), and focal lymph node metastasis (n = 1) were noted
during pathologic evaluation. All these findings, excluding splenic artery
invasion, were visible on CT or MRI.
View larger version (111K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 8A. —71-year-old man with 3-month history of swelling and pain in
peripheral joints, painful cutaneous lumps, and fever. Radiograph of right
hand shows lytic lesions (arrows) in phalanges, especially in fifth
finger, which most likely represent areas of fat necrosis rather than
metastasis.
|
|
View larger version (152K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 8B. —71-year-old man with 3-month history of swelling and pain in
peripheral joints, painful cutaneous lumps, and fever. Photograph shows skin
nodule (arrow) at knee that was proven to be fat necrosis.
|
|
View larger version (133K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 8C. —71-year-old man with 3-month history of swelling and pain in
peripheral joints, painful cutaneous lumps, and fever. Axial CT scan reveals
large, exophytic mass (arrow) with central cystic area in pancreatic
tail.
|
|
On microscopic examination, all tumors consisted of cells arranged in nests
and acinar structures with lobulation and thin strands of fibrovascular
stroma. Tumor cells had focally abundant apical eosinophilic cytoplasm with
round to slightly irregular basally located nuclei. Results of a periodic
acid–Schiff (PAS) stain with diastase digestion were available in seven
cases and revealed fine zymogen granules in the cytoplasm of the tumor cells.
Results of immunostaining were positive for 
-1-antichymotrypsin
(n = 6), -1-antitrypsin (n = 5), keratin (CAM5.2 or
AE1/AE3) (n = 5), and lipase (n = 1) antibodies. Results of
synaptophysin and chromogranin staining were focally positive in some cases.
Tumor cells were negative for carcinoembryonic antigen (CEA) and mucicarmine
staining. These immunohistochemical results are consistent with the diagnosis
of acinar cell carcinoma. Electron microscopic evaluation revealed zymogen
granules in four patients, which also supports the diagnosis of acinar cell
carcinoma.
Discussion
To our knowledge, no comprehensive report describing the CT and MRI
features of acinar cell carcinoma is currently available. The imaging features
of acinar cell carcinoma, as illustrated in individual case reports, have been
variable
[5–13].
Therefore, the objective of this study was to describe the imaging features of
a series of pathologically proven acinar cell carcinomas.
Although no sex predilection was observed in our series, the tumor has been
reported to be more frequent in men
[1,
3]. Excluding children and
adolescents, the mean age of patients in the largest series to date was 60
years [3], which is similar to
that of our series. There seems to be no racial predilection. However, whites
constitute most of the patients in clinicodemographic studies and in our
patient population [1,
3].
Patients usually present with symptoms related to either local mass effect
or metastases [1]. Symptoms
usually are nonspecific and include abdominal pain, loss of appetite, weight
loss, nausea, and vomiting
[1–3].
The most common presenting symptom in our series was abdominal pain (55%),
similar to the findings in prior reports
[3]. The most common clinical
sign at presentation is a palpable abdominal mass, whereas jaundice is
considered rare. Although only one patient in our series presented with a
liver metastasis, approximately half of the patients in prior series had
metastases at presentation, with the liver being the most common site
[3]. Extraabdominal metastases
are rare [1].
Interestingly, acinar cell carcinoma can cause hyperlipasemia, which may
lead to diffuse subcutaneous nodules and polyarthropathy
[1,
3,
5,
6,
14]. Subcutaneous nodules are
generally widely distributed, erythematous, and painful and may be
misinterpreted as erythema nodosum or as metastases
[3,
6]. Arthropathy is caused by
periarticular fat necrosis and involves peripheral joints such as the ankles,
knees, wrists, and small joints of the hands and feet. Radiographs of the
osseous lesions typically show multiple lytic areas that might be mistaken for
metastases involving both cancellous and cortical bones
[6]. These lesions are often
located beneath subcutaneous lesions. Although frequently reported, these
lipase-induced stigmata are uncommon with acinar cell carcinoma
[2,
3]. In the series by Holen et
al. [3], they were seen in less
than 10% of patients. Only one of our patients (9%) presented with signs and
symptoms of hyperlipasemia. In addition to an elevated serum lipase level,
some patients with acinar cell carcinoma also may have an elevated serum
amylase level, peripheral eosinophilia, and a markedly elevated serum
-fetoprotein level [1,
15]. In fact, in our series,
elevated levels of serum lipase and amylase were found in three (27%) and two
patients (18%), respectively. An isolated case of acinar cell carcinoma
secreting insulinlike growth factors that caused hypoglycemia has also been
reported in the literature
[16].
Tumors that are amenable to surgical resection and are 10 cm or smaller are
associated with a longer patient survival than are larger and unresectable
tumors [2]. Older age (> 60
years), the presence of symptoms of lipase secretion, the location of tumor in
the head of the pancreas, and the presence of metastasis at presentation are
associated with a decreased chance of survival
[2]. Radiation and chemotherapy
are indicated only for palliative purposes
[1].
In our series, a particular tumor location did not predominate, although
the pancreatic head was the most common site. Approximately half of the tumors
were also located in the head of the pancreas in the series by Holen et al.
[3]. Most tumors in our series
were well marginated (91%) and partially or completely exophytic (82%). These
features can be used to differentiate acinar cell carcinoma from other
pancreatic tumors because they are rare in more common pancreatic
neoplasms.
Tumors in our series were slightly smaller (7.1 cm) than those described in
prior reports (10.6 cm) in mean diameter
[1,
2]. Tumors were homogeneous and
solid when small. Five tumors in our series were solid, and all of them were
less than 5 cm in largest diameter (mean diameter, 3.5 cm). Although cystic
changes have been reported to be rare in a series of 28 patients
[2], six of our patients (55%)
had tumors with a varying degree of cystic change. In four, cystic areas
constituted more than 75% of the tumor. Another interesting finding was that
tumors with cystic areas (mean diameter, 10.1 cm) were substantially larger
than purely solid ones (mean diameter, 3.5 cm). This finding is likely due to
greater necrosis in the larger tumors resulting from impairment of the blood
supply.
Limited published data are available regarding the enhancement pattern of
acinar cell carcinoma [9,
10,
15]. In our series, the tumors
typically enhanced homogeneously but less than surrounding pancreatic
parenchyma. However, the patients were not routinely examined with arterial
phase imaging. Mustert et al.
[9] reported a case of acinar
cell carcinoma that was hypervascular on arterial phase imaging.
On histopathologic examination, pure acinar cell carcinoma has two
predominant cellular patterns of growth: an acinar pattern consisting of cells
growing in well-formed acini and a solid pattern characterized by sheets and
cords of cells in a fibrovascular stroma
[3]. PAS staining after
diastase digestion characteristically reveals PAS-positive granules
corresponding to zymogen granules
[2]. Mucin stains are typically
negative. Acinar cell carcinoma displays a unique immunochemical staining
pattern: strongly positive for the digestive enzymes of exocrine pancreas such
as trypsin, chymotyripsin, lipase, and phospholipase A2 and
negative or only focally positive for neuroendocrine markers such
synaptophysin, chromogranin, glucagon, somatostatin, gastrin, and vasoactive
intestinal peptide [2]. Results
of keratin stains are always positive especially when the CAM5.2 antibody is
used. Another acinar cell secretory product, -1-antitrypsin, is
diffusely expressed in most tumors
[1]. In our series, all tumors
showed acinar differentiation by these criteria. In addition, staining for
mucicarmine and CEA produced negative results. Results for mucicarmine and CEA
are usually positive in ductal adenocarcinoma but not in acinar cell
carcinoma.
Immunohistochemical detection of a minor endocrine component in acinar cell
carcinoma is not rare
[1–3,
12,
17,
18], and we detected such a
component in a minority of the cases in our series. Klimstra et al.
[2] detected minor endocrine
components in 42% of their cases. Tumors displaying both acinar and endocrine
features that constitute more than 25% of the cells have been termed
"mixed acinar–endocrine carcinomas." They are otherwise
histologically similar to the pure acinar cell carcinomas and have been
included in other published pathologic series studying acinar cell carcinoma
[2,
3]. We also identified two
cases of mixed acinar–endocrine carcinoma and one case of mixed
acinar–ductal origin; however, we chose not to include these cases in
our study group.
The radiologic differential diagnosis of acinar cell carcinoma includes
ductal adenocarcinoma, neuroendocrine tumor, solid and pseudopapillary tumor,
pancreaticoblastoma, mucinous cystic neoplasm, and pseudocyst
[1]. It is important to
differentiate these neoplasms because treatment and prognosis differs
significantly for these various entities. Pancreatic ductal adenocarcinoma is
the most common primary pancreatic malignancy. This tumor is usually smaller
than acinar cell carcinoma and virtually never contains calcification or
cystic degeneration [19].
Unlike acinar cell carcinoma, pancreatic ductal adenocarcinoma is not well
marginated and is almost always locally invasive. Neuroendocrine tumor is
typically more vascular than acinar cell carcinoma and, therefore, may enhance
more than the pancreatic parenchyma; this tumor shows clinical evidence of
abnormal hormone secretion. However, nonfunctioning endocrine tumors may
present as large well-marginated masses with internal hemorrhagic-cystic areas
and thus may not be distinguishable from acinar cell carcinoma
[20]. Solid and
pseudopapillary tumors may also mimic acinar cell carcinoma. These tumors are
well-marginated, large, encapsulated tumors with solid and cystic areas;
however, they are seen almost exclusively in young women, in which acinar cell
carcinoma only rarely occurs, and have a better prognosis
[21]. Pancreatoblastomas are
extremely rare malignant epithelial tumors with acinar differentiation and are
histologically similar to acinar cell carcinoma
[1]. However,
pancreatoblastomas usually occur in infants and children
[1]. They are more aggressive
than acinar cell carcinoma and often present with liver metastases. Finally,
thick-walled pancreatic pseudocysts may resemble an acinar cell carcinoma, as
in one of our patients. However, a history of pancreatitis is almost always
present.
In conclusion, pure acinar cell carcinoma of the pancreas, although rare,
has distinctive CT and MRI features that allow radiologists to render an
accurate diagnosis. It typically presents as a well-marginated, exophytic mass
that enhances homogeneously and less than surrounding pancreas when small and
contains cystic areas due to necrosis when large.
References
- Solcia E, Capella C, Kloppel G. Tumors of the exocrine pancreas.
In: Rosai J, Sorbin L, eds. Atlas of tumor pathology,
3rd series, fasc. 20 Washington, DC: Armed Forces Institute of Pathology,1997
: 31–144
- Klimstra DS, Heffess CS, Oertel JE, Rosai J. Acinar cell carcinoma
of the pancreas: a clinicopathologic study of 28 cases. Am J Surg
Pathol 1992;16:815
–837[Medline]
- Holen KD, Klimstra DS, Hummer A, et al. Clinical characteristics
and outcomes from an institutional series of acinar cell carcinoma of the
pancreas and related tumors. J Clin Oncol2002; 20:4673
–4678[Abstract/Free Full Text]
- Ordonez NG, Mackay B. Acinar cell carcinoma of the pancreas.
Ultrastruct Pathol2000; 24:227
–241[Medline]
- Ashley SW, Lauwers GY. Case records of the Massachusetts General
Hospital: weekly clinicopathological exercises—case 37-2002, a
69-year-old man with painful cutaneous nodules, elevated lipase levels, and
abnormal results on abdominal scanning N Engl J Med2002; 347:1783
–1791[Free Full Text]
- Radin DR, Colletti PM, Forrester DM, Tang WW. Pancreatic acinar
cell carcinoma with subcutaneous and intraosseous fat necrosis.
Radiology1986; 158:67
–68[Abstract/Free Full Text]
- Ishizaki A, Koito K, Namieno T, Nagakawa T, Murashima Y, Suga T.
Acinar cell carcinoma of the pancreas: a rare case of an
alpha-fetoprotein-producing cystic tumor. Eur J Radiol1995; 21:58
–60[Medline]
- Lim JH, Chung KB, Cho OK, Cho KS. Acinar cell carcinoma of the
pancreas: ultrasonography and computed tomography findings. Clin
Imaging 1990;14:301
–304[Medline]
- Mustert BR, Stafford-Johnson DB, Francis IR. Appearance of acinar
cell carcinoma of the pancreas on dual-phase CT. AJR1998; 171:1709[Free Full Text]
- Sahani D, Prasad SR, Maher M, Warshaw AL, Hahn PF, Saini S.
Functioning acinar cell pancreatic carcinoma: diagnosis on mangafodipir
trisodium (Mn-DPDP)-enhanced MRI. J Comput Assist
Tomogr 2002;26:126
–128[Medline]
- Hashimoto M, Matsuda M, Watanabe G, et al. Acinar cell carcinoma of
the pancreas with intraductal growth: report of a case.
Pancreas 2003;26:306
–308[Medline]
- Chen JD, Wu MS, Tien YW, Kuo KT, Chang MC, Lin JT. Acinar cell
carcinoma with hypervascularity. J Gastroenterol
Hepatol 2001;16:107
–111[Medline]
- Lingg G, Nebel G, Angelkort A, Kloppel G. Computed tomography in a
new type of acinar cell tumour of the pancreas: the solid acinar cell tumour
with cystic degeneration. Eur J Radiol1981; 1:232
–235[Medline]
- MacMahon HE, Brown PA, Shen EM. Acinar cell carcinoma of the
pancreas with subcutaneous fat necrosis.
Gastroenterology1965; 49:555
–559[Medline]
- Eriguchi N, Aoyagi S, Hara M, et al. Large acinar cell carcinoma of
the pancreas in a patient with elevated serum AFP level. J
Hepatobiliary Pancreat Surg2000; 7:222
–225[Medline]
- Mizuta Y, Isomoto H, Futuki Y, et al. Acinar cell carcinoma of the
pancreas associated with hypoglycemia: involvement of "big"
insulin-like growth factor-II. J Gastroenterol1998; 33:761
–765[Medline]
- Muramatsu T, Kijima H, Tsuchida T, et al. Acinarislet cell tumor of
the pancreas: report of a malignant pancreatic composite tumor. J
Clin Gastroenterol 2000;31:175
–178[Medline]
- Hartman GG, Ni H, Pickleman J. Acinar cell carcinoma of the
pancreas. Arch Pathol Lab Med2001; 125:1127
–1128[Medline]
- Mergo PJ, Helmberger TK, Buetow PC, Helmberger RC, Ros PR.
Pancreatic neoplasms: MR imaging and pathologic correlation.
RadioGraphics1997; 17:281
–301[Abstract]
- Buetow PC, Parrino TV, Buck JL, et al. Islet cell tumors of the
pancreas: pathologic-imaging correlation among size, necrosis and cysts,
calcification, malignant behavior, and functional status.
AJR 1995;165:1175
–1179[Abstract/Free Full Text]
- Cantisani V, Mortele KJ, Levy A, et al. MR imaging features of
solid pseudopapillary tumor of the pancreas in adult and pediatric patients,
AJR 2003;181:395
–401[Abstract/Free Full Text]
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
V. A. Sahni and K. J. Mortele
The Bloody Pancreas: MDCT and MRI Features of Hypervascular and Hemorrhagic Pancreatic Conditions
Am. J. Roentgenol.,
April 1, 2009;
192(4):
923 - 935.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. M. Chung, M. D. Travis, and R. M. Conran
From the Archives of the AFIP: Pancreatic Tumors in Children: Radiologic-Pathologic Correlation.
RadioGraphics,
July 1, 2006;
26(4):
1211 - 1238.
[Abstract]
[Full Text]
[PDF]
|
|
|
Top
Abstract
Introduction
